Wells Fargo’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-5,183
| Closed | -$8K | – | 7667 |
|
2022
Q1 | $8K | Sell |
5,183
-7,839
| -60% | -$12.1K | ﹤0.01% | 6019 |
|
2021
Q4 | $31K | Buy |
13,022
+12,086
| +1,291% | +$28.8K | ﹤0.01% | 5697 |
|
2021
Q3 | $6K | Buy |
936
+325
| +53% | +$2.08K | ﹤0.01% | 6023 |
|
2021
Q2 | $5K | Sell |
611
-518
| -46% | -$4.24K | ﹤0.01% | 6032 |
|
2021
Q1 | $9K | Sell |
1,129
-12,164
| -92% | -$97K | ﹤0.01% | 6024 |
|
2020
Q4 | $121K | Buy |
13,293
+7
| +0.1% | +$64 | ﹤0.01% | 5130 |
|
2020
Q3 | $147K | Sell |
13,286
-2,211
| -14% | -$24.5K | ﹤0.01% | 4926 |
|
2020
Q2 | $115K | Buy |
15,497
+4,806
| +45% | +$35.7K | ﹤0.01% | 4963 |
|
2020
Q1 | $66K | Sell |
10,691
-543
| -5% | -$3.35K | ﹤0.01% | 5040 |
|
2019
Q4 | $56K | Buy |
11,234
+500
| +5% | +$2.49K | ﹤0.01% | 5233 |
|
2019
Q3 | $81K | Buy |
10,734
+10,695
| +27,423% | +$80.7K | ﹤0.01% | 5157 |
|
2019
Q2 | $0 | Buy |
+39
| New | – | ﹤0.01% | 6320 |
|